Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

Vitamin D concentrations were lower in the abdominal obesity and metabolic syndrome groups than in controls.

Source: Abstract. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Cross-sectional study.

Cross-sectional study

Examines a population at a particular point in time.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

This cross-sectional study was conducted in March 2014 during routine systematic health examinations of first: and second-year students at the Faculty of Medicine in Foča, University of East Sarajevo.

Source: Methods.

All participants were informed about the study objectives and provided written informed consent before enrollment.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Adipokine, endocrine, and fibrinolysis-related alterations across abdominal obesity and metabolic syndrome phenotypes in young adults

Cross-sectional study · Frontiers in Endocrinology · 2026

Original publication title

Adipokine, endocrine, and fibrinolysis-related alterations across abdominal obesity and metabolic syndrome phenotypes in young adults

Dragana Puhalo Sladoje; Ilija Dragojević; Dejan Bokonjić; Lamija Zečević-Pašić; Olivera Čančar; Berina Hasanefendić; Bojana Kisić

Copyright © 2026 Puhalo Sladoje, Dragojević, Bokonjić, Zečević-Pašić, Čančar, Hasanefendić and Kisić.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Young adults with abdominal obesity showed measurable endocrine, adipokine, insulin-resistance, and fibrinolysis-related alterations, including those who did not meet criteria for metabolic syndrome. The A/L ratio and PAI-1 may provide complementary information, with the A/L ratio more closely associated with abdominal obesity and PAI-1 more closely associated with metabolic syndrome in exploratory models. These findings support further evaluation of phenotype-based biomarker profiling for characterizing early cardiometabolic dysregulation in young adults and should be confirmed in larger, sex-balanced cohorts.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

Abdominal obesity in young adults may reflect a biologically active metabolic phenotype, even before full metabolic syndrome develops. However, how endocrine, adipokine, insulin-resistance, and fibrinolysis-related biomarkers vary across early metabolic phenotypes remains incompletely understood. This study examined whether selected circulating biomarkers differ among normal-weight controls, young adults with abdominal obesity, and those with metabolic syndrome.

Source: Background

Abstract: What methods does the paper describe?

This cross-sectional secondary biomarker analysis included 175 young adults aged 19 to 21 years who were classified according to International Diabetes Federation criteria as controls (n = 106), abdominal obesity (n = 37), or metabolic syndrome (n = 32). Fasting insulin, HOMA-IR, cortisol, 25-hydroxyvitamin D, leptin, adiponectin, the adiponectin/leptin ratio (A/L ratio), ghrelin, and plasminogen activator inhibitor-1 (PAI-1) were analyzed. Between-group differences were assessed using nonparametric tests, ordered trends were evaluated across the phenotype gradient, sensitivity analyses were adjusted for sex, smoking status, and physical activity, and penalized logistic regression was used to explore biomarker associations with abdominal obesity and metabolic syndrome.

Source: Methods

Abstract: Results

Insulin, HOMA-IR, cortisol, leptin, and PAI-1 showed positive ordered phenotype-related patterns, whereas ghrelin, adiponectin, and the A/L ratio showed negative ordered patterns. Vitamin D concentrations were lower in the abdominal obesity and metabolic syndrome groups than in controls. The strongest between-group effects were observed for PAI-1, cortisol, ghrelin, adiponectin, and the A/L ratio. Overall group effects remained significant after adjustment and false discovery rate correction. In mutually adjusted penalized models, the A/L ratio remained associated with abdominal obesity, whereas PAI-1 remained associated with metabolic syndrome.

Source: Results

Abstract: Conclusion

Young adults with abdominal obesity showed measurable endocrine, adipokine, insulin-resistance, and fibrinolysis-related alterations, including those who did not meet criteria for metabolic syndrome. The A/L ratio and PAI-1 may provide complementary information, with the A/L ratio more closely associated with abdominal obesity and PAI-1 more closely associated with metabolic syndrome in exploratory models. These findings support further evaluation of phenotype-based biomarker profiling for characterizing early cardiometabolic dysregulation in young adults and should be confirmed in larger, sex-balanced cohorts.

Source: Conclusion
Authors’ abstract

Background

Abdominal obesity in young adults may reflect a biologically active metabolic phenotype, even before full metabolic syndrome develops. However, how endocrine, adipokine, insulin-resistance, and fibrinolysis-related biomarkers vary across early metabolic phenotypes remains incompletely understood. This study examined whether selected circulating biomarkers differ among normal-weight controls, young adults with abdominal obesity, and those with metabolic syndrome.

Methods

This cross-sectional secondary biomarker analysis included 175 young adults aged 19 to 21 years who were classified according to International Diabetes Federation criteria as controls (n = 106), abdominal obesity (n = 37), or metabolic syndrome (n = 32). Fasting insulin, HOMA-IR, cortisol, 25-hydroxyvitamin D, leptin, adiponectin, the adiponectin/leptin ratio (A/L ratio), ghrelin, and plasminogen activator inhibitor-1 (PAI-1) were analyzed. Between-group differences were assessed using nonparametric tests, ordered trends were evaluated across the phenotype gradient, sensitivity analyses were adjusted for sex, smoking status, and physical activity, and penalized logistic regression was used to explore biomarker associations with abdominal obesity and metabolic syndrome.

Results

Insulin, HOMA-IR, cortisol, leptin, and PAI-1 showed positive ordered phenotype-related patterns, whereas ghrelin, adiponectin, and the A/L ratio showed negative ordered patterns. Vitamin D concentrations were lower in the abdominal obesity and metabolic syndrome groups than in controls. The strongest between-group effects were observed for PAI-1, cortisol, ghrelin, adiponectin, and the A/L ratio. Overall group effects remained significant after adjustment and false discovery rate correction. In mutually adjusted penalized models, the A/L ratio remained associated with abdominal obesity, whereas PAI-1 remained associated with metabolic syndrome.

Conclusion

Young adults with abdominal obesity showed measurable endocrine, adipokine, insulin-resistance, and fibrinolysis-related alterations, including those who did not meet criteria for metabolic syndrome. The A/L ratio and PAI-1 may provide complementary information, with the A/L ratio more closely associated with abdominal obesity and PAI-1 more closely associated with metabolic syndrome in exploratory models. These findings support further evaluation of phenotype-based biomarker profiling for characterizing early cardiometabolic dysregulation in young adults and should be confirmed in larger, sex-balanced cohorts.

Publication and source details

Original title: Adipokine, endocrine, and fibrinolysis-related alterations across abdominal obesity and metabolic syndrome phenotypes in young adults

Dragana Puhalo Sladoje; Ilija Dragojević; Dejan Bokonjić; Lamija Zečević-Pašić; Olivera Čančar; Berina Hasanefendić; Bojana Kisić

Frontiers in Endocrinology · 2026

* Correspondence: Ilija Dragojević, ilija.dragojevic@med.pr.ac.rs

†ORCID: Dragana Puhalo Sladoje, orcid.org/0000-0002-4336-466X; Ilija Dragojević, orcid.org/0000-0002-2292-7486; Dejan Bokonjić, orcid.org/0000-0002-7749-5326; Lamija Zečević-Pašić, orcid.org/0000-0003-1110-0675; Berina Hasanefendić, orcid.org/0000-0002-9610-5020; Bojana Kisić, orcid.org/0000-0002-3018-1186

Copyright © 2026 Puhalo Sladoje, Dragojević, Bokonjić, Zečević-Pašić, Čančar, Hasanefendić and Kisić.2026Puhalo Sladoje, Dragojević, Bokonjić, Zečević-Pašić, Čančar, Hasanefendić and Kisićhttps://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.The author(s) declared that financial support was received for this work and/or its publication. The Article Processing Charge (APC) was supported by the Faculty of Medicine Foča, University of East Sarajevo, Bosnia and Herzegovina, in accordance with the Rulebook on Financial Support for the Publication of Scientific Papers (Decisions No. 01-3-36 and No. 01-3-353).

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-10T22:02:20.259051+00:00

DOI: 10.3389/fendo.2026.1900593 · PMC13457479